Zisch AH, Kalo MS, Chong LD, Pasquale EB (May 1998). „Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region”. Oncogene16 (20): 2657–70. DOI:10.1038/sj.onc.1201823. PMID9632142.
Zisch AH, Pazzagli C, Freeman AL, Schneller M, Hadman M, Smith JW, Ruoslahti E, Pasquale EB (January 2000). „Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses”. Oncogene19 (2): 177–87. DOI:10.1038/sj.onc.1203304. PMID10644995.
Yu HH, Zisch AH, Dodelet VC, Pasquale EB (July 2001). „Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor”. Oncogene20 (30): 3995–4006. DOI:10.1038/sj.onc.1204524. PMID11494128.
nih.gov
ncbi.nlm.nih.gov
Chan J, Watt VM (August 1991). „eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases”. Oncogene6 (6): 1057–61. PMID1648701.
Zisch AH, Kalo MS, Chong LD, Pasquale EB (May 1998). „Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region”. Oncogene16 (20): 2657–70. DOI:10.1038/sj.onc.1201823. PMID9632142.
Zisch AH, Pazzagli C, Freeman AL, Schneller M, Hadman M, Smith JW, Ruoslahti E, Pasquale EB (January 2000). „Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses”. Oncogene19 (2): 177–87. DOI:10.1038/sj.onc.1203304. PMID10644995.